June 15, 2020
BONESUPPORT FORTIFY PATIENT ENROLLEMENT FINALIZED EARLIER THAN ORIGINAL PLAN
Media
June 15, 2020
Oncopeptides reports positive results from full data set of Phase 2 HORIZON trial in triple-class refractory multiple myeloma patients
June 12, 2020
Aprea Therapeutics Presents Results From French Phase Ib/II Clinical Trial of APR-246 (Eprenetapopt) and Azacitidine in Patients with TP53 Mutant Myelodysplastic Syndromes and Acute Myeloid Leukemia at the 25th European Hematology Association Annual Meeting
June 11, 2020
Oncopeptides hosts a virtual symposium at the 25th European Hematology Association Congress on Challenges in Managing Patients with Myeloma
June 10, 2020
Doctrin appoints Anna-Karin Edstedt Bonamy as new CEO
June 10, 2020
Nordic Nanovector ASA: Annual General Meeting held
June 08, 2020
BONESUPPORT starts its own sales organization in the Netherlands
June 04, 2020
Targovax enters collaboration with Leidos to add checkpoint inhibitor functionality to ONCOS viruses
June 03, 2020
Aprea Therapeutics Completes Full Enrollment of Phase 3 Clinical Trial in TP53 Mutant Myelodysplastic Syndromes (MDS)
June 02, 2020
Nordic Nanovector to Present at Upcoming Jefferies Virtual Healthcare Conference and ABG Sundal Collier Virtual Oncology Seminar
